Michael Buck, PhD, professor of biochemistry in the Jacobs School, recently received NIH funding to explore how molecular readers of DNA access and activate seemingly hidden genes.
Mirum Pharmaceuticals, Inc. today reported financial results for the third quarter 2025 and provided a business update. "Mirum is well positioned heading into 2026 with strong commercial momentum and ...
This column is a necessary sequel to my October Arc on the role Elders play in telling stories from History. I will tell a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback